Literature DB >> 19562100

Synthesis of protected norcysteines for SPPS compatible with Fmoc-strategy.

Manoj P Samant1, Jean E Rivier.   

Abstract

We report the synthesis of racemic Alloc-Ncy(Tmob)-OH, the resolution of its methyl ester, and demonstrate its application to form a norcystine bridge in octreotide-amide using the Fmoc-strategy on solid phase. N-Alloc and S-Tmob protections of norcysteine (Ncy) were found to be a preferred choice for Fmoc-strategy over three other protected norcysteines synthesized i.e. Fmoc-Ncy(tBu)-OH, Alloc-Ncy(tBu)-OH and Alloc-Ncy(Trt)-OH.

Entities:  

Year:  2007        PMID: 19562100      PMCID: PMC2701708          DOI: 10.1016/j.tetlet.2007.05.082

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  4 in total

1.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

Authors:  W Bauer; U Briner; W Doepfner; R Haller; R Huguenin; P Marbach; T J Petcher
Journal:  Life Sci       Date:  1982-09-13       Impact factor: 5.037

2.  Norcystine, a new tool for the study of the structure-activity relationship of peptides.

Authors:  Manoj P Samant; Jean E Rivier
Journal:  Org Lett       Date:  2006-05-25       Impact factor: 6.005

3.  Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.

Authors:  Jean Rivier; Judit Erchegyi; Carl Hoeger; Charleen Miller; William Low; Sandra Wenger; Beatrice Waser; Jean-Claude Schaer; Jean Claude Reubi
Journal:  J Med Chem       Date:  2003-12-18       Impact factor: 7.446

4.  Studies on peptides. CLI. Syntheses of cystine-peptides by oxidation of S-protected cysteine-peptides with thallium(III) trifluoroacetate.

Authors:  N Fujii; A Otaka; S Funakoshi; K Bessho; T Watanabe; K Akaji; H Yajima
Journal:  Chem Pharm Bull (Tokyo)       Date:  1987-06       Impact factor: 1.645

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.